中藥調(diào)控NF-κB信號(hào)通路防治心肌梗死的研究進(jìn)展

打開文本圖片集

中圖分類號(hào)R965；R285 文獻(xiàn)標(biāo)志碼A 文章編號(hào) 1001-0408（2025）14-1807-06

nOI 106030/iiccn 1001 040820251421

ABSTRACTMyocardialinfarction（MI）referstoanacuteclinicalsyndromeofmyocardialnecrosisduetopersistentischemia and hypoxia，resulting from the sharp reduction or interuption of coronary blood flow.Nuclear factor κB （NF- κB ）isthekey factorininducinginflammatorresponse，anditisinvolvedintheproductionofpro-inflammatoryfactorsandmyocardialcel apoptosis.This article systematically describes the molecular regulation mechanism of the NF- κB signaling pathway in MI，and reviewstherelatedresearchonthepreventionandtreatmentofMIthrough theregulationofthissignaling pathwaybyactive ingredientsandcompoundformulasfromtraditionalChinesemedicine（TCM）.IthasbeenfoundthatactiveingredientsfromTCM， such as ginsenoside Rg3 ，baicalein，curcumin，tanshinone IA ，gambogic acid，as well as compound formulas，including Qili qiangxincapsules，Yiqi huoxuedecoction，Lingbao huxindan，Danhong injection，Baoyuandecoctioncombinedwith Taohong siwudecoction，canimproveyocardial fibrosis，aleviate inflammatoryresponses，andinhibitcardiomyocyteapoptosisby suppressing the NF- ?κB signaling pathway. Thereby，they achieve the goal of preventing and treating MI.

KEYWORDSmyocardial infarction;NF- σκB ；traditional Chinese medicine；active ingredients；compound formula

心肌梗死（myocardialinfarction，MI）是一種全球發(fā)病率和死亡率均較高的疾病，全球每年約有700萬人患此病[]。（剩余15630字）